event,time
10 years old ,0
male ,0
born by caesarean section ,-720
birth weight 2100 g ,-720
birth length 48 cm ,-720
prominent forehead ,-720
relative macrocephaly ,-720
limb asymmetry ,-720
5th finger clinodactyly of both hands ,-720
2/3 toe syndactyly of both legs feet ,-720
hypomethylation of the 11p15 region of the paternal chromosome ,-504
delayed motor development ,-336
walked independently in 16th month of life ,-336
hepatic dysfunction ,-336
increased concentration of alanine aminotransferase ,-336
increased concentration of aspartate aminotransferase ,-336
increased creatine kinase level ,-336
diagnosis of Duchenne muscular dystrophy ,-336
mutation of the maternal DMD gene located on the X chromosome ,-336
exon deletion 49–50 ,-336
often falling ,-240
tiptoed ,-240
Achilles tendon contractures ,-240
Gover’s syndrome ,-240
enlarged calves ,-240
corticosteroids treatment ,-240
prednisone ,-240
deflazacort ,-192
qualified for G-CSF treatment ,-192
G-CSF treatment ,-192
sepsis ,-144
hypoglycaemia ,-144
neurological symptoms ,-144
glucose level of 14 mg/dl ,-144
hypospadias ,-144
episodes of sinus tachycardia ,-72
heart murmur ,-72
cardiological diagnostics ,-72
propranolol ,-72
growth hormone deficiency ,-72
rhGH treatment ,-72
dysmorphic features ,-72
slightly limb asymmetry ,-72
hypotonia ,-72
malocclusion ,-72
hypospadias ,-72
pubertal status ,-72
auxological examination ,-72
height 115.9 cm ,-72
weight 19.9 kg ,-72
body mass index 14.8 kg/m2 ,-72
target height 182.5 cm ,-72
height velocity 4.3 cm/year ,-72
glucose and insulin levels in oral glucose tolerance test ,-72
IGF-1 and IGFBP-3 concentrations ,-72
MRI of the hypothalamic-pituitary region ,-72
transparent septum cyst ,-72
rhGH treatment started ,0
improvement of auxological parameters ,12
height velocity increased ,12
level of IGF-1 increased ,12
BMI increased ,12
worsening of glucose metabolism ,12
increasing insulin resistance ,12
HbA1c elevated ,12
distance covered in 6MWT decreased ,12
"abnormal, weakened gait ",12
behavioural treatment with lifestyle modification ,12
rhGH dose reduced ,12
growth 2.8 cm ,6
rhGH therapy discontinued ,18
auxological and hormonal evaluation ,18
change of height during life and rhGH treatment ,18
change of BMI during life and rhGH treatment ,18
body mass composition ,12
densitometry ,12
bone density test of the lumbar spine ,12
Z-score –2.2 ,12
